H&T Presspart to Exhibit at Respiratory Drug Delivery (RDD®) 2026

H&T Presspart is pleased to announce its participation as an exhibitor at the upcoming Respiratory Drug Delivery (RDD®) 2026 conference, taking place at The Westin Kierland Resort & Spa in Phoenix, Arizona, USA, from 10–14 May 2026.

RDD® is one of the most established international conferences dedicated to drug delivery to the lungs and nasal routes, bringing together scientists, engineers, clinicians, regulatory experts and industry leaders to share the latest advances in respiratory science and technology.

As part of the exhibition, H&T Presspart will present its extensive portfolio of inhalation components, including MDI cans, actuators, and dose counters, along with its range of inhalation devices such as the Sunriser® high-performance dry powder inhaler technology. Visitors to the stand will also be able to learn all about our range of services for the design development and industrialisation of inhalation drug delivery devices.

RDD® is one of the most established international conferences dedicated to drug delivery to the lungs and nasal routes, bringing together scientists, engineers, clinicians, regulatory experts and industry leaders to share the latest advances in respiratory science and technology.

The RDD® 2026 exhibition provides an important platform for knowledge exchange and networking, with dedicated poster and exhibition sessions designed to foster interaction between industry and academia. H&T Presspart’s participation underscores its ongoing commitment to advancing respiratory drug delivery science and contributing to innovation in the sector.

To arrange a meeting during the conference please contact the team.